Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

NCT03114969

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Beek, Netherlands
  • GSK Investigational Site Beek en Donk, Netherlands
  • GSK Investigational Site Eindhoven, Netherlands
  • GSK Investigational Site Hengelo, Netherlands
View all 13 locations
View Trial Details
Completed

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT03478683

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Gold River, California, United States
  • GSK Investigational Site Clearwater, Florida, United States
  • GSK Investigational Site Clearwater, Florida, United States
  • GSK Investigational Site DeBary, Florida, United States
View all 57 locations
View Trial Details
Completed

Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT03034967

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Topeka, Kansas, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 64 locations
View Trial Details
Completed

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT03478696

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 57 locations
View Trial Details

Related conditions